Načítá se...
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
Inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease, are disabling conditions characterised by chronic, relapsing inflammation of the gastrointestinal tract. Current treatments are not universally effective or, in the case of therapeutic antibodies, are hampered by immune res...
Uloženo v:
| Vydáno v: | J Crohns Colitis |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5881740/ https://ncbi.nlm.nih.gov/pubmed/28158411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjx003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|